Conditions: ADHD
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 217
Healthy volunteers: no

Brief summary:
To assess the efficacy and safety of efficacy of MTS compared to placebo

Detailed description:
To assess the efficacy and safety of efficacy of MTS compared to placebo, as determined by the change in the clinician completed ADHD Rating Scale - Version 4th Edition (ADHD-RS-IV), in the symptomatic treatment of adolescents (aged 13-17 years) diagnosed with ADHD.

Arms:
arm 1: dose optimization of 4 doses of the MTS transdermal patch over the same duration of wear arm 2: Daily application of matching MTS Placebo Patch

Interventions: intervention 1: methylphenidate transdermal system intervention 2: Placebo
Intervention descriptions: intervention 1: dose optimization of 4 doses of the MTS transdermal patch over the same duration of wear intervention 2: Placebo patch

Protocol document: